TAM
ADPT icon

Tyers Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Tyers Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$17K Buy
+560
New +$22.9K ﹤0.01% 960

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tyers Asset Management's ADPT Position: Q3 2019 in Review

Tyers Asset Management opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2019: 560 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #960 among its holdings.

117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.

  • Tyers Asset Management held 560 shares of Adaptive Biotechnologies worth $17K as of Q3 2019.
  • Adaptive Biotechnologies was a new Tyers Asset Management position in Q3 2019.
  • Adaptive Biotechnologies made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #960 holding.
  • 117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.